Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Overview
Cancer Epidemiology, Biomarkers & Prevention is a renowned journal published by the American Association for Cancer Research, in collaboration with the American Society of Preventive Oncology. This esteemed publication focuses on cutting-edge research in cancer epidemiology, biomarkers, and prevention strategies. With a multidisciplinary approach, the journal aims to advance our understanding of cancer etiology, identify risk factors, and develop effective prevention strategies to combat this global health challenge.
Details
Details
Abbr.
Cancer Epidemiol Biomarkers Prev
Start
1991
End
Continuing
Frequency
Monthly
p-ISSN
1055-9965
e-ISSN
1538-7755
Country
United States
Language
English
Specialties
Biochemistry
Oncology
Public Health
Oncology
Public Health
Metrics
Metrics
h-index / Ranks: 579
215
SJR / Ranks: 1592
1688
CiteScore / Ranks: 3323
6.50
JIF / Ranks: 2461
3.8
Recent Articles
1.
Black E, Allemani C, Dudding T
Cancer Epidemiol Biomarkers Prev
. 2025 Mar;
PMID: 40079833
Background: Skin cancers (SCs) are the third most common cancer worldwide, with incidence increasing. Metabolic syndrome (MetS) is a cluster of metabolic abnormalities strongly associated with the development of cardiovascular...
2.
Lee S, Song D, Kim U, Jee S, Lee K
Cancer Epidemiol Biomarkers Prev
. 2025 Mar;
PMID: 40079752
Background: Telomere length shortens with age and is associated with an increased risk of numerous chronic diseases. However, the causal direction between telomere length and cancer risk remains uncertain. This...
3.
Omofuma O, Rusiecki J, Petrick J, Falk R, Wheeler W, Pfeiffer R, et al.
Cancer Epidemiol Biomarkers Prev
. 2025 Mar;
PMID: 40079721
Background: We previously identified associations of esophageal adenocarcinoma (EA) risk with four inflammation-related candidate biomarkers: TNFR2, IL17A, VEGFR3 and resistin. Methods: We aimed to replicate these candidates and discover novel...
4.
Woodhouse P, Jackson L, Kammer M, Godfrey C, Antic S, Zou Y, et al.
Cancer Epidemiol Biomarkers Prev
. 2025 Mar;
:OF1-OF7.
PMID: 40072122
Background: The heterogeneous biology of cancer subtypes, especially in lung cancer, poses significant challenges for biomarker development. Standard model building techniques often fall short in accurately incorporating various histologic subtypes...
5.
McKenzie L, Allshouse W, Johnson D, DeVoe C, Cockburn M, Ghosh D
Cancer Epidemiol Biomarkers Prev
. 2025 Mar;
PMID: 40067119
Background: Children living in upstream oil and natural gas (O&G) areas may be exposed to leukemogens and at increased risk for acute lymphocytic leukemia (ALL). Methods: We conducted a case-control...
6.
Forman D, Yang M, Chien R, Nguyen H, Wong C, Kim J, et al.
Cancer Epidemiol Biomarkers Prev
. 2025 Mar;
PMID: 40063522
Background: Alcoholic beverages and the main metabolite of alcohol, acetaldehyde, are known carcinogens. A genetic variant in aldehyde dehydrogenase 2 (ALDH2, G>A, rs671) leads to decreased efficiency in metabolizing acetaldehyde...
7.
Wu Y, de Groen P, Natafgi N, Cai C, Wu D, Xirasagar S
Cancer Epidemiol Biomarkers Prev
. 2025 Mar;
PMID: 40063509
Background: Black Americans experience higher colorectal cancer (CRC) incidence than Whites, despite undergoing prevention screenings similar to Whites since 2010. We compared Black and White patients' colorectal adenoma status at...
8.
Kleinstern G, Robinson D, Rimsza L, Larson M, King R, Nowakowski G, et al.
Cancer Epidemiol Biomarkers Prev
. 2025 Mar;
PMID: 40047811
Background: Diffuse large B-cell lymphoma (DLBCL) is clinically heterogeneous, and gene expression profiling has identified at least two biologically distinct DLBCL subtypes defined by their cell-of-origin (COO): germinal center B-cell...
9.
Gibbs D, Small B, Autuori I, Leong S, Ali E, Kenney J, et al.
Cancer Epidemiol Biomarkers Prev
. 2025 Mar;
PMID: 40036058
Background: Recent genome-wide association studies (GWAS) have identified new susceptibility loci for melanoma, but their associations with multiple primary melanoma (MPM) are unclear. Methods: We investigated the associations of 69...
10.
Gallicchio L, Burnett-Hartman A, Filipski K, Shelburne N, Freedman A
Cancer Epidemiol Biomarkers Prev
. 2025 Mar;
PMID: 40036057
Background: The goal of this manuscript was to provide an overview of the current National Cancer Institute (NCI)-funded large cancer epidemiology survivor cohorts (CESCs). Methods: Large CESCs were defined as...